Enzymotec Ltd. to Present at the Jefferies 2017 Global Healthcare Conference
25 May 2017 - 10:30PM
Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and
marketer of innovative bio-active lipid ingredients and medical
foods, today announced that Mr. Erez Israeli, the Company’s Chief
Executive Officer, will present at the Jefferies 2017 Global
Healthcare Conference being held on June 6-9, 2017 at the Grand
Hyatt New York in New York City.
Mr. Israeli is scheduled to present on Thursday,
June 8, 2017 at 4:30 PM EDT. The presentation will take place in 7
Imperial. The presentation will be followed immediately by a
breakout session at 5:00 PM EDT in the Booth Room.
Mr. Israeli and Mr. Oren Bryan, the Company’s
Chief Financial Officer, will also be available to participate in
one-to-one meetings with investors during the conference.
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty lipid-based
products and solutions. The Company develops, manufactures and
markets innovative bio-active lipid ingredients, as well as final
products, based on sophisticated processes and technologies.
Contact
The Ruth Group
Tram Bui / Alexander Lobo
Phone: 646-536-7035 / 7037
tbui@theruthgroup.com
alobo@theruthgroup.com
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Aug 2024 to Sep 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Enzymotec Ltd. - Ordinary Shares (delisted) (NASDAQ): 0 recent articles
More News Articles